ECM
AVNS

ExodusPoint Capital Management’s Avanos Medical AVNS Stock Holding History

ExodusPoint Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,100
Closed -$635K – 1955
2020
Q3 		$635K Buy
+19,100
New +$610K 0.01% 891

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

ExodusPoint Capital Management's AVNS Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Avanos Medical (AVNS) stake by 28% in Q1 2026, selling an estimated $2.22M and leaving 421,504 shares worth $5.91M. The position accounts for 0.05% of the portfolio, ranked #387.

ExodusPoint Capital Management first reported a position in AVNS in Q1 2020 and has held it in 19 quarters since. The position peaked at $15.3M in Q2 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • ExodusPoint Capital Management held 421,504 shares of Avanos Medical worth $5.91M as of Q1 2026.
  • ExodusPoint Capital Management sold 164,981 Avanos Medical shares in Q1 2026, an estimated $2.22M.
  • Avanos Medical made up 0.05% of ExodusPoint Capital Management's portfolio in Q1 2026, its #387 holding.
  • ExodusPoint Capital Management first reported a position in Avanos Medical in Q1 2020 and has held it in 19 quarters since.
  • ExodusPoint Capital Management's Avanos Medical position peaked at $15.3M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.